%0 Conference Paper
%A Scalco, RS
%A Morrow, J
%A Manole, A
%A Skorupinska, I
%A Bellin, A
%A Ricciardi, F
%A Matthews, E
%A Hanna, M
%A Fialho, D
%B 11th Annual UK Neuromuscular Translational Research Conference
%C Cambridge
%D 2018
%F discovery:10047475
%I Elsevier
%K Periodic Paralysis, Channelopathy, Hypokalaemic Periodic Paralysis, CMAP, Phase II, Drug repurposing study, Long exercise test, Neurophysiology, Outcome measure, Treatment
%N S1
%P S27-S27
%T RCT of Bumetanide in Hypokalaemic Periodic Paralysis (HypoPP) using abductor digiti minimi compound muscle action potential (CMAP) as an objective outcome measure
%U https://discovery.ucl.ac.uk/id/eprint/10047475/
%V 28
%Z This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.